RNA detection on a microfluidic platform using Thyclotides.

Area of Science:

• Biochemistry
• Molecular Biology
• Nanotechnology

Background:

• Nucleic acid detection is crucial for diagnosing diseases, with polymerase chain reaction (PCR) being a standard method.
• PCR limitations include challenges in point-of-care and resource-limited settings due to the need for enzymatic amplification.

Purpose of the Study:

• To develop a novel nucleic acid detection assay for direct RNA detection without enzymatic amplification.
• To engineer peptide nucleic acids (PNAs) with enhanced binding affinity and bio-orthogonal properties for improved diagnostic capabilities.

Main Methods:

• Chemically modified PNAs, termed thyclotides, were synthesized incorporating trans-3,4-diaminotetrahydrofuran units.
• Two stereochemistries of THF monomers (R,R and S,S) were used to create PNA variants with specific binding properties.
• A microfluidic assay combined thyclotides with gold nanoparticles and silver enhancement for signal detection of synthetic HIV-1 RNA.

Main Results:

• The thyclotide assay directly detected synthetic HIV-1 RNA without enzymatic amplification, achieving a limit of detection of 0.5 pM.
• This represents a ~100-fold improvement over previous PNA-based detection systems.
• The assay demonstrated concentration-dependent signal intensity for semi-quantitative analysis and was unaffected by control sequences.

Conclusions:

• Thyclotides offer enhanced binding affinity and bio-orthogonal properties for direct nucleic acid detection.
• The developed microfluidic assay shows promise for sensitive and potentially point-of-care RNA diagnostics.
• This non-enzymatic amplification approach advances nucleic acid detection technologies for disease diagnosis.